Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.87p
   
  • Change Today:
    -0.13p
  • 52 Week High: 5.34
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 885,597
  • Market Cap: £29.86m
  • Beta: 0.10

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -239.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.4 n/a
Pr/Book 2.1  
Latest F'cast
Revenue 138.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.50 (49.43) (21.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 13.09 (32.38) (5.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Company Announcements

ACCRUFeR® launched in Canada 11-Mar-2025 07:00 RNS
PDMR Transaction Notification 13-Feb-2025 16:15 RNS
Grant of Share Options 13-Feb-2025 07:00 RNS

STX ShareCast News

Shield Therapeutics appoints Anders Lundstrom as... 27-Jan-2025 ShareCast
Shield Therapeutics secures $10m investment, ann... 06-Dec-2024 ShareCast
Shield Therapeutics reports strong quarter for A... 29-Oct-2024 ShareCast

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 2.87p
Change Today -0.13p
% Change -4.44 %
52 Week High 5.34
52 Week Low 1.23
Volume 885,597
Shares Issued 1,041.69m
Market Cap £29.86m
Beta 0.10

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.59% below the market average43.59% below the market average43.59% below the market average43.59% below the market average43.59% below the market average
70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average
Price Trend
25.28% below the market average25.28% below the market average25.28% below the market average25.28% below the market average25.28% below the market average
10.20% above the sector average10.20% above the sector average10.20% above the sector average10.20% above the sector average10.20% above the sector average
Income Not Available
Growth
63.91% above the market average63.91% above the market average63.91% above the market average63.91% above the market average63.91% above the market average
80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average

STX Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
11:34 1,000 @ 3.00p
11:20 49,119 @ 2.80p
10:58 2,070 @ 2.80p
10:48 20,000 @ 2.80p
10:34 10,000 @ 2.90p

STX Key Personnel

CEO Anders Lundstrom

Top of Page